Investigation of Heart Failure Status Over Time Using Respiratory Parameters

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00494117

Enrollment

Registered

2007-06-29

Start date

2007-06-30

Completion date

2010-03-31

Last updated

2010-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Congestive, Sleep Apnea Syndromes

Brief summary

The purpose of the study is to investigate respiratory indicators for clinically important changes in Heart Failure status over time.

Interventions

DEVICEApneaLink

A two channel sleep screening device for the assessment of Sleep Disordered Breathing.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Moderate to severe Heart Failure (as determined by Echocardiogram or by treating physician)

Exclusion criteria

* Malignant disease affecting gas exchange or respiratory parameters * Medications compromising breathing with no adverse affects on heart failure * Clinically significant (moderate to severe) asthma requiring therapy * Chronic parenchymal lung disease (FEV1/FVC ratio = 65% or as determined by the treating physician) * Severe pulmonary hypertension * Heart failure due to alcohol abuse or chemotherapy * Narcotic abuse/intravenous drug use (including HIV+ and hepatitis C) * Alcohol consumption \> 80g/day * Patients receiving home Oxygen * Methicillin- resistant Staphylococcus aureus infection * Narcolepsy * Cataplexy * Enrolled in any concurrent study, that may confound the results of this study. * Inability or refusal to sign the Patient Consent Form * Inability or refusal to adhere to protocol requirements

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026